Improving Adherence to Ticagrelor in Patients After Acute Coronary Syndrome: Talking Face to Face is Better than a Phone Call
Curr Vasc Pharmacol
.
2020;18(3):302-303.
doi: 10.2174/1570161117999190820150930.
Authors
Laurent Metzinger
1
,
Valérie Metzinger-Le Meuth
2
Affiliations
1
EA4666 Hematim, Curs, CHU Amiens Picardie, Avenue Rene Laennec, Salouel, F-80054, Amiens, France.
2
Inserm U1148 Laboratory for Vascular Translational Science (LVTS), University Paris 13-Sorbonne Paris Cite, UFR Smbh, 74 rue Marcel Cachin, F-93017 Bobigny, France.
PMID:
31433760
DOI:
10.2174/1570161117999190820150930
No abstract available
Publication types
Editorial
Comment
MeSH terms
Acute Coronary Syndrome*
Humans
Platelet Aggregation Inhibitors
Ticagrelor*
Ticlopidine
Substances
Platelet Aggregation Inhibitors
Ticagrelor
Ticlopidine